United Laboratories, Inc.

unilab.com.ph

Driven by its genuine desire to make the lives of people better by providing quality products and services, Unilab is now the biggest pharmaceutical company in the Philippines, with a market share of some 20 percent which it has consistently maintained for more than three decades. Its portfolio includes some of the biggest prescription and consumer healthcare brands in the country.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

news image

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More

Pharma Tech

ILC DOVER ANNOUNCES NORTH AMERICA EXPANSION TO MEET GROWING DEMAND

ILC Dover | March 11, 2022

news image

ILC Dover LP specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business and entry into sterile liquid handling and chemicals content market. This investment will generate additional production capacity for its single-use powder storage, s...

Read More

Views and Analysis

EVEREST MEDICINES ANNOUNCES PARTNER CALLIDITAS THERAPEUTICS RECEIVES FDA PRIORITY REVIEW FOR FULL APPROVAL OF NEFECON®

PRNewswire | August 21, 2023

news image

Everest Medicines announced that U.S. Food and Drug Administration (FDA) has accepted the submission for the supplemental New Drug Application (sNDA) for Nefecon® from its partner Calliditas Therapeutics AB and granted Priority Review. The Prescription Drug User Fee Act (PDUFA) goal date is Dec. 20, 2023. "We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-disease thera...

Read More

PHARMA TECH

CGI AND KÖRBER ANNOUNCE GLOBAL PARTNERSHIP TO ENABLE PHARMACEUTICAL AND LIFE SCIENCES CLIENTS TO IMPROVE PRODUCTION OPERATIONS

PR Newswire | January 23, 2024

news image

CGI, one of the largest business and IT consulting companies in the world, today announced a partnership with Körber aimed at enabling pharmaceutical and life sciences companies to improve their production processes by combining CGI's end-to-end services with Körber's Werum PAS-X Manufacturing Execution System (MES) Suite. The global partnership is designed to help clients increase efficiency, accuracy, and safety in pharma products and enhance decision-making through acc...

Read More
news image

Pharmacy Market

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More
news image

Pharma Tech

ILC DOVER ANNOUNCES NORTH AMERICA EXPANSION TO MEET GROWING DEMAND

ILC Dover | March 11, 2022

ILC Dover LP specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business and entry into sterile liquid handling and chemicals content market. This investment will generate additional production capacity for its single-use powder storage, s...

Read More
news image

Views and Analysis

EVEREST MEDICINES ANNOUNCES PARTNER CALLIDITAS THERAPEUTICS RECEIVES FDA PRIORITY REVIEW FOR FULL APPROVAL OF NEFECON®

PRNewswire | August 21, 2023

Everest Medicines announced that U.S. Food and Drug Administration (FDA) has accepted the submission for the supplemental New Drug Application (sNDA) for Nefecon® from its partner Calliditas Therapeutics AB and granted Priority Review. The Prescription Drug User Fee Act (PDUFA) goal date is Dec. 20, 2023. "We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-disease thera...

Read More
news image

PHARMA TECH

CGI AND KÖRBER ANNOUNCE GLOBAL PARTNERSHIP TO ENABLE PHARMACEUTICAL AND LIFE SCIENCES CLIENTS TO IMPROVE PRODUCTION OPERATIONS

PR Newswire | January 23, 2024

CGI, one of the largest business and IT consulting companies in the world, today announced a partnership with Körber aimed at enabling pharmaceutical and life sciences companies to improve their production processes by combining CGI's end-to-end services with Körber's Werum PAS-X Manufacturing Execution System (MES) Suite. The global partnership is designed to help clients increase efficiency, accuracy, and safety in pharma products and enhance decision-making through acc...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us